Categories: New Launches

ResMed launches ‘AirSenseTM 10 Autoset’ to treat Obstructive Sleep Apnea

·Designed to provide unprecedented comfort and clinical efficiency at every stage of treatment.

· Offers better therapy, greater comfort and ease of use to patients with sleep disorders

New Delhi, September 17, 2015: ResMed India, a medical device company that specializes in treating sleep disordered breathing and other chronic diseases has launched its latest generation auto adjusting pressure device AirSenseTM 10Autoset which is designed to offer better therapy, greater comfort and ease of use to the patients.

 

Packed with cutting-edge features and technology, AirSenseTM 10Autoset is designed to provide unprecedented comfort and clinical efficiency. Each device comes with integrated heated humidifier, HumidAir™ and enhanced Climate Control through ClimateLineAirTM which helps to deliver the optimal temperature and humidity. It also comes with enhanced AutosetTM algorithm thus delivering the ultimate experience in sleep.

This advanced APAP device that comes with additional features like:

ü AutoRampTM with sleep onset detection is designed to make therapy as comfortable as possible.

ü Cheyne Stokes Respiration Detection provides valuable information to the physicians on the continued health of their patient.

ü AutosetTM Response feature offers all the benefits ofAutoSet therapy with added options of gentler pressure increases for a more comfortable night’s sleep.

ü Ambient Light Sensor adjusts the brightness of the screen based on the amount of light in the room.

ü QuickNavTM feature gives a user-friendly interface.

ü Easy-Breathe Motor makes the device noiseless and allows the patient and the bed-partner a quiet sleep every night.

Speaking on the launch of the product, Mr.Aparajito Mukherjee, Managing Director, ResMed India Pvt. Ltd. said, “The launch of the AirSense TM 10 Autoset reflects our commitment to provide innovative solutions to improve the quality of life of patients. It is based on close partnership and extensive research with clinicians, patients and caregivers and our experience in sleep disorders.”

Sleep disorders is a growing concern and represents a significant number in India. Recent estimates of OSA prevalence suggest that 13 per cent of men and six per cent of women in India have OSA

Corporate Comm India(CCI Newswire)

The Pharma Times News Bureau

Recent Posts

8 Ways Insomnia Affects Skin Health & How To Avoid It

By Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru Insomnia, the persistent inability…

4 days ago

Breaking New Ground in Migraine Care: A Landmark Session on Diagnosis and Treatment

Illuminating Latest Advances in Migraine Diagnosis and Treatment New Delhi, December 21, 2024: In a…

4 days ago

Healthcare Startups to Watch Out for in 2025

New Delhi, December 20, 2024: The healthcare sector is undergoing a transformation fueled by technological…

5 days ago

DKMS’s First Global Impact Report of 2023 Serves as New Ray of Hope for Blood Cancer Patients Worldwide

National, December 20, 2024: DKMS just published its first Global Impact Report that outlines the organization's…

5 days ago

Sterling Biotech to start world’s first precision fermentation-based dairy protein factory in Gujarat

Ahmedabad, December 19, 2024: Sterling Biotech Limited, a joint venture between Perfect Day and Zydus, has…

6 days ago

Pioneers in Senior Care, Antara, Partners with Leading Diagnostics Player Dr. Lal PathLabs to Strengthen its Geriatric Care Services

New Delhi, December 19, 2024: Antara Senior Care, an integrated eco-system provider for lifestyle and…

6 days ago